Lower close as first quarter ends

The markets extended its losses to close lower with the Dow dropping 65 points to 20,663 on the final trading day of the first quarter. Nasdaq slipped 2 points to 5,911.


On the upside


Affiliates of investment fund New Mountain Partners will take TRC Companies (NYSE: TRR) private in an all cash transaction valued at a premium of $17.55 per common share.


Dicerna Pharmaceuticals (Nasdaq: DRNA) narrowed fourth quarter losses more than expected.


Fang Holdings (NYSE: SFUN) narrowed losses for the fourth quarter and announced that the company would return to its open-platform strategy.


On the downside


A district court invalidated four of Acorda Therapeutics' (Nasdaq: ACOR) patents pertaining to AMPYRA .


Proteostasis Therapeutics (Nasdaq: PTI) widened losses for the fourth quarter.

DarioHealth (Nasdaq: DRIO) priced its public offering of 1.45 million common shares at the discounted price of $3.10 per share.


In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 index lost 5 points to 2,362. Bitcoin soared $32 to $1067.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.